Intensive Behavioral Therapy for Obesity Combined with Liraglutide 3.0 mg: A Randomized Controlled Trial
Wadden, Thomas A., Walsh, Olivia A., Berkowitz, Robert I., Chao, Ariana M., Alamuddin, Naji, Gruber, Kathryn, Leonard, Sharon, Mugler, Kimberly +2 more·2019·Obesity
Cited by (115)
Items 101–115 of 115
- USE OF LIRAGLUTIDE FOR WEIGHT LOSS IN OBESE OR OVERWEIGHT PATIENTS ASSOCIATED WITH COMORBIDITIES: A LITERATURE REVIEWAmanda Nascentes Coelho dos Santos Omer, A.L. Pereira Neto, Ana Carolina Rocha Borges, Ana Julia Matarelli Pereira de Almeida, Ana Luiza Lacerda Ribeiro, Ana Madeira Carneiro Braga de Freitas, Arthur de Lima Tanure, Bruna Aparecida da Silva, Clara Rubião Pimenta, João Vitor Carmo De Novaes et al. · 2023 · International Journal of Health Science
- Use of Pharmacotherapy in Obesity ManagementTham Kwang Wei · 2024 · The Singapore Family Physician
- Benefits managers’ attitudes toward obesity treatment coverageCaroline Ben Nathan, Jennifer Ben Nathan, Yung-Tang Chou, Sukanya M. Joshi, Christine Gallagher, Ariana M. Chao · 2024 · Obesity Research & Clinical Practice
- OS EFEITOS COLATERAIS DOS ANÁLOGOS DE GLP-1 EM INDIVÍDUOS NÃO DIABÉTICOS: UMA REVISÃO INTEGRATIVA DA LITERATURAGabriela Santos Coelho, Gabriella Mendanha Sales, Aline Ferreira Bezerra, Gustavo Coelho Santos, Thaise Gomes e Silva · 2024 · Revista Contemporânea
- Super response to liraglutide in people with obesity: A case report and literature reviewSonsoles Gutiérrez Medina, Elena Sánchez Campayo, Sonsoles Guadalix, Javier Escalada · 2024 · Endocrinología Diabetes y Nutrición (English ed )
- Role of Incretin Mimetics in the Management of ObesityShilpa Chugh Garcha, Sanjay Kalra · 2025 · Springer eBooks
- Effects of anti-obesity drugs on cardiometabolic risk factors in pediatric population with obesity: a systematic review and meta-analysis of randomized controlled trialsAhmad Bin Aamir, Rabia Latif, Joory Osamah Fallatah, Jood Faisal Alqoofi, Hadeel Adnan Alsalman, Fatimah Abdulkarim Almarzoq · 2025 · International Journal of Adolescent Medicine and Health
- “Super-Responders” to Liraglutide Monotherapy and the Growing Evidence of Efficacy of GLP-1 Analogues in Obesity Management: A Longitudinal Prospective Cohort StudyEllina Lytvyak, Eduardo L. Grunvald, Devika Shreekumar, Peter Rye, Olexandr Troshyn, Sarah Cawsey, Aldo J. Montaño‐Loza, Arya Mitra Sharma, Renuca Modi · 2025 · Obesities
- Effects of Korean Medicine Combined with Dietitian-Led Low-Carbohydrate Diet Coaching on Eating Attitudes: A Retrospective Study Using the KEAT-26 QuestionnaireMinwoo Bang, Suyong Shin, Jae‐Joong Kim, Minwhee Kang, Donghun Lee, Jae‐Joong Kim, Chunghee Kim, Jiyoung Son, Seonghyeon Jeon, Byungsoo Kang · 2025 · Journal of Korean Medicine for Obesity Research
- Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists for Psychological Well‐Being and Depressive Symptoms: A Systematic Review and Meta‐Analysis of Randomized Controlled TrialsTsung-Hsuan Hung, Chyi-Rong Chen, Chih‐Wei Hsu, Andre F. Carvalho, Brendon Stubbs, Ping‐Tao Tseng, Liang‐Jen Wang, Paul‐Yang Lin · 2026 · Human Psychopharmacology Clinical and Experimental
- Prevention and Management of Recurrent Weight Gain After Bariatric Surgery: Integrating Behavioural, Pharmacological and Procedural ApproachesSally Louise Tucker, Samer Humadi · 2026 · Obesity Surgery
- Impact of Glucagon-Like Peptide-1/Glucose-Dependent Insulinotropic Polypeptide Therapy and Nutrition Counseling on Body CompositionKathryn Hoffman, Peter Gillespie, Candace Smith · 2026 · Journal of Nutrition
- Pharmacotherapy for Children and Adolescents With Overweight or Obesity: A Systematic Review and Network Meta‐Analysis of Randomized Controlled TrialsLi Luo, Tingting Huang, Zijing Yan, Yunyun Qi, Qige Wei, Hui Wang, Nan Liu, Yongli Xuan, Yuehua Chen, Jianglin Zhao et al. · 2026 · Diabetes Obesity and Metabolism
- Combination Pharmacotherapies for Obesity—Current Evidence and Future DirectionsAbul B. M. Kamrul-Hasan, Arnav Kalra, Nitin Kapoor, Deep Dutta, Kunal Mahajan, Robin Maskey, Syed Abbas Raza · 2026 · Endocrinology Diabetes & Metabolism
- Weight Reduction Heterogenicity and Mediators of GLP ‐ 1RAs and Dual Agonists for Individuals With Obesity: A Meta‐AnalysisDifei Lu, Na Li, Zhenfang Yuan, Ying Gao · 2026 · Clinical Obesity